Researchers examined data from 280 women undergoing laparoscopic myomectomy at five tertiary hospitals in Sichuan Province, China. The team compared patients who received pelvic drainage and rectal misoprostol against those who did not. They focused on outcomes like postoperative fever, pelvic infection, pain levels, and hospital stay length.
The analysis showed that pelvic drainage independently increased the risk of postoperative fever. In contrast, the use of rectal misoprostol significantly lowered the risk of both fever and pelvic infection. Additionally, misoprostol helped reduce drainage volume and duration among patients who had drainage tubes.
No adverse events or discontinuations were reported in this short-term follow-up. However, because this was a non-randomized observational study, results depend on institutional protocols and surgeon choices. Readers should understand that pelvic drainage offers no clear benefit and might increase morbidity, while misoprostol appears helpful in this specific context.